Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-16-004016
Accepted
2016-03-23 00:15:12
Documents
1
Effectiveness Date
2016-03-22
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 598
  Complete submission text file 9999999995-16-004016.txt   1720
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1214
Type: EFFECT | Act: 33 | File No.: 333-208850 | Film No.: 161522279
SIC: 2834 Pharmaceutical Preparations